Skip to main content
. 2011 Oct 13;16(6):430–443. doi: 10.3109/13625187.2011.614029

Figure 1.

Figure 1

Patient flow through the trial. NO MAC, nomegestrol acetate; E2, oestradiol; EE, ethinylestradiol; DRSP, drospirenone; AE, adverse event.